Andrew Charles Adams - Beth Israel Deaconess Medical Center, Harvard Medical School

基本信息

浏览量：41

职业迁徙

个人简介

Andrew Charles Adams currently works at the Lilly Research Laboratories, Eli Lilly. Andrew does research in Endocrinology, Neuroscience and Physiology.

研究兴趣

论文共 86 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Discovery, Development, and Clinical Proof of Mechanism of LY3463251, a Long-Acting GDF15 Receptor Agonist

Olivier Benichou,Tamer Coskun,Malgorzata D. Gonciarz,Parag Garhyan,Andrew C. Adams,Yu Du,James D. Dunbar,Jennifer A. Martin,Kieren J. Mather,Richard T. Pickard,Vincent L. Reynolds,Deborah A. Robins, Simbarashe P. Zvada,Paul J. Emmerson

CELL METABOLISM（2023）

引用39浏览0WOS引用

Targeting Hepatic Serine-Arginine Protein Kinase 2 Ameliorates Alcohol-Associated Liver Disease by Alternative Splicing Control of Lipogenesis

Guannan Li,Hanqing Chen,Feng Shen, Steven Blake Smithson,Gavyn Lee Shealy, Qinggong Ping,Zerong Liang,Jingyan Han,Andrew C. Adams,Yu Li,Dechun Feng,Bin Gao,Masahiro Morita,Xianlin Han,Tim H. Huang,Nicolas Musi,Mengwei Zang

Hepatology（2023）

引用9浏览0WOS引用

FGF21 Contributes to Metabolic Improvements Elicited by Combination Therapy with Exenatide and Pioglitazone in Patients with Type 2 Diabetes

Ricardo J. Samms,Christine C. Cheng,Marcel Fourcaudot,Sami Heikkinen,Ahmed Khattab,John Adams,Eugenio Cersosimo,Curtis Triplitt, Curtis Puckett,Kostas Tsintzas,Andrew. C. Adams,Muhammad A. Abdul-Ghani,Ralph A. DeFronzo,Luke Norton

AJP Endocrinology and Metabolism（2022）

引用7浏览0WOS引用

Neutralizing monoclonal antibodies for treatment of COVID-19

Peter C. Taylor,Andrew C. Adams,Matthew M. Hufford,Inmaculada de la Torre,Kevin Winthrop,Robert L. Gottlieb

NATURE REVIEWS IMMUNOLOGY（2021）

引用527浏览0WOSNATURE引用

527

The Neutralizing Antibody, LY-CoV555, Protects Against SARS-CoV-2 Infection in Nonhuman Primates

Bryan E. Jones,Patricia L. Brown-Augsburger,Kizzmekia S. Corbett,Kathryn Westendorf,Julian Davies,Thomas P. Cujec,Christopher M. Wiethoff,Jamie L. Blackbourne,Beverly A. Heinz,Denisa Foster,Richard E. Higgs,Deepa Balasubramaniam,Lingshu Wang,Yi Zhang,Eun Sung Yang,Roza Bidshahri,Lucas Kraft,Yuri Hwang,Stefanie Zentelis, Kevin R. Jepson,Rodrigo Goya,Maia A. Smith, David W. Collins,Samuel J. Hinshaw,Sean A. Tycho,Davide Pellacani,Ping Xiang,Krithika Muthuraman,Solmaz Sobhanifar,Marissa H. Piper,Franz J. Triana,Jorg Hendle,Anna Pustilnik,Andrew C. Adams,Shawn J. Berens,Ralph S. Baric,David R. Martinez,Robert W. Cross,Thomas W. Geisbert,Viktoriya Borisevich,Olubukola Abiona,Hayley M. Belli,Maren de Vries,Adil Mohamed,Meike Dittmann,Marie Samanovic,Mark J. Mulligan,Jory A. Goldsmith,Ching-Lin Hsieh,Nicole Johnson,Daniel Wrapp,Jason S. McLellan,Bryan C. Barnhart,Barney S. Graham,John R. Mascola,Carl L. Hansen,Ester Falconer

Science translational medicine（2021）

引用418浏览0WOSSCIENCE引用

418

Neutralizing Monoclonal Antibodies for Treatment of COVID-19

Peter C. Taylor,Andrew C. Adams,Matthew M. Hufford,Inmaculada de la Torre,Kevin Winthrop,Robert L. Gottlieb

Nature Reviews Immunology（2021）

引用0浏览0引用

Variant Selection, Characterization, and Impact on Antibody SARS-CoV-2 Neutralization

James Dunyak,Beverly A. Heinz,Robert W. Siegel,Peter Vaillancourt, Benjamin Jones,D. Johnson,Viktoriya Borisevich,Thomas W. Geisbert, Richard Cross,Andrew Adams

Topics in antiviral medicineno. 1 (2021): 153-153

引用0浏览0引用

Neuroprotective Effects of the FGF21 Analogue LY2405319

Claire Ruehlmann, David Dannehl, Marcus Brodtrueck,Andrew C. Adams,Jan Stenzel,Tobias Lindner,Bernd J. Krause,Brigitte Vollmar,Angela Kuhla

JOURNAL OF ALZHEIMERS DISEASE（2021）

引用17浏览0WOS引用

Bamlanivimab Prevents COVID-19 Morbidity and Mortality in Nursing-Home Setting

Max Cohen,Ajay Nirula, Matthew J. Mulligan, Cynthia G. Whitney,Mary Marovich,Alexander Stemer,A. C. Adams,Andrew E. Schade,Jack Knorr,Jay Tuttle, John Sabo,Paul Klekotka, Longjiao Shen,Daniel Skovronsky

Topics in antiviral medicineno. 1 (2021): 32-33

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn